How Ozempic is affecting people with eating disorders and the food industry
UC expert discusses need for more research with WVXU's Cincinnati Edition
GLP-1 drugs, sold under brand names including Ozempic and Wegovy, are growing more popular for weight loss. At the same time, experts say the drugs are dramatically altering people's relationship with food and the food and beverage industry itself.
The University of Cincinnati's Susan McElroy, MD, told WVXU's Cincinnati Edition that a trial she led found that liraglutide, a drug in the GLP-1 class, was efficacious for weight loss for individuals with bipolar disorder and statistically reduced binge eating behavior based on self-reported data.
However, McElroy said that in general, it is difficult to conduct research focusing on GLP-1's effect on mental health and eating disorders.
"I’m just really sad that the GLP-1 companies haven’t taken eating disorders seriously," said McElroy, the Linda and Harry Fath endowed professor in the Department of Psychiatry & Behavioral Neuroscience in UC’s College of Medicine, chief research officer at the Lindner Center of HOPE and a UC Health physician.
Anecdotally, McElroy said some patients have reported GLP-1s triggering anorexia, while others say the drugs have been the only solution to address binge eating disorder. The wide range of outcomes highlights the need for more thorough research, she said.
"The industry has basically ignored eating disorders," she said. "I guess they assume that by getting at obesity they’re going to get most of the people with eating disorders, but that’s just not the truth."
Listen to the Cincinnati Edition segment.
Featured photo at top of a semaglutide injection pen. Photo/aprott/iStock.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.